Reliability of MR perfusion-weighted and diffusion-weighted imaging mismatch measurement methods

American Journal of Neuroradiology

Volumn 28, Issue 9, 2007, Pages 1674-1678

  Luby, Marie ^a   Warach, S ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOTEPLASE; GADOLINIUM; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ARTICLE; BRAIN PERFUSION; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; DRUG DOSE ESCALATION; FIBRINOLYTIC THERAPY; HUMAN; IMAGING SYSTEM; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PERFUSION WEIGHTED IMAGING; PROSPECTIVE STUDY; RELIABILITY; SINGLE DRUG DOSE; STROKE;

ALGORITHMS; BRAIN; DIFFUSION MAGNETIC RESONANCE IMAGING; ECHO-PLANAR IMAGING; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; PERFUSION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STROKE;

EID: 35349001661     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A0643     Document Type: Article

References (10)

1. Hacke W, Albers G, Al-Rawi Y, et al. for The DIAS Study Group. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS). Stroke 2005;36:66-73
2. Furlan AJ, Eyding D, Albers GW, et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227-31
3. Schellinger PD, Fiebach JB. Perfusion-weighted imaging/diffusion- weighted mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: pro. Stroke 2005;36:1098-101
4. Neumann-Haefelin T, Wittsack HJ, Wenserski F, et al. Diffusion- and perfusion-weighted MRI: the DWI/PWI mismatch region in acute stroke. Stroke 1999;30:1591-97
5. Chalela JA, Kang DW, Luby M, et al. Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: insights into the pathophysiology of acute stroke in the thrombolysis era. Ann Neurol 2004;55:105-12
6. Lee DK, Kim JS, Kwon SU, et al. Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease: early diffusion-weighted imaging study. Stroke 2005;36:2583-88
7. Weisskoff RM, Chesler D, Boxerman JL. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time? Magn Reson Med 1993;29:553-58
8. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10
9. Butcher KS, Parsons M, MacGregor L, et al. Refining the perfusion-diffusion mismatch hypothesis. Stroke 2005;36:1153-59
10. Coutts SB, Simon JE, Tomanek AI, et al. Reliability of assessing percentage of diffusion-perfusion mismatch. Stroke 2003;34:1681-83